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ABSTRACT Chlamydiae are well known for their species speciﬁcity and tissue tropism, and yet the individual species and strains
showremarkablegenomicsyntenyandshareanintracellulardevelopmentalcycleuniqueinthemicrobialworld.Onlyarela-
tivelyfewchlamydialgeneshavebeenlinkedtospeciﬁcdiseaseortissuetropism.Hereweshowthatchlamydialspeciesassoci-
ated with human infections, Chlamydia trachomatis and C. pneumoniae, exhibit unique requirements for Src-family kinases
throughout their developmental cycle. Utilization of Src-family kinases by C. trachomatis includes tyrosine phosphorylation of
thesecretedeffectorTarpduringtheentryprocess,afunctionalroleinmicrotubule-dependenttrafﬁckingtothemicrotubule
organizingcenter,andarequirementforSrc-familykinasesforsuccessfulinitiationofdevelopment.Nonhumanchlamydial
species C. caviae and C. muridarum show none of these requirements and, instead, appear to be growth restricted by the activi-
ties of Src-family kinases. Depletion of Src-family kinases triggers a more rapid development of C. caviae with up to an 800%
increaseininfectiousprogenyproduction.Collectively,theresultssuggestthathumanchlamydialspecieshaveevolvedrequire-
mentsfortyrosinephosphorylationbySrc-familykinasesthatarenotseeninotherchlamydialspecies.TherequirementforSrc-
familykinasesthusrepresentsafundamentaldistinctionbetweenchlamydialspeciesthatwouldnotbereadilyapparentin
genomiccomparisonsandmayprovideinsightsintochlamydialdiseaseassociationandspeciesspeciﬁcity.
IMPORTANCE Chlamydiae are well known for their species speciﬁcity and tissue tropism as well as their association with unique
diseases.Aparadoxintheﬁeldrelatestotheremarkablegenomicsyntenyshownamongchlamydiaeandtheveryfewchlamydial
geneslinkedtospeciﬁcdiseases.WehavefoundthatdifferentchlamydialspeciesexhibituniquerequirementsforSrc-family
kinases.ThesedifferingrequirementsforSrc-familykinaseswouldnotbeapparentingenomiccomparisonsandappeartobea
previouslyunrecognizeddistinctionthatmayprovideinsightstoguideresearchinchlamydialpathogenesis.
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C
hlamydiae are Gram-negative obligate intracellular bacteria
that are the causative agents of several signiﬁcant human dis-
eases. Chlamydia trachomatis includes over 15 serologically de-
ﬁned variants, or serovars, associated with different diseases and
tissue tropisms. These include the etiologic agents of trachoma,
themostcommoncauseofinfectiousblindness,whileothersero-
vars cause sexually transmitted diseases (1). C. pneumoniae is a
common cause of community-acquired pneumonia (2). C. muri-
darum and C. caviae were isolated from mice and guinea pigs,
respectively (3, 4), and are not known to infect humans.
Chlamydiae are characterized by a biphasic life cycle, alter-
nating between infectious elementary bodies (EBs) and repli-
cative reticulate bodies (RBs) (5). Following endocytosis by a
host cell, chlamydiae reside within a vacuole termed an inclu-
sion, which is nonfusogenic with the endosomal/lysosomal
pathway but acquires sphingomyelin and cholesterol from the
Golgi apparatus (6–8). Once modiﬁed by de novo-synthesized
chlamydial proteins, the nascent inclusion is trafﬁcked to the
perinuclearregion,whereitistypicallyobservedincloseappo-
sition with the host cell centrosomes (9–14). This initial traf-
ﬁcking is dependent upon the host microtubule network and
the minus-end microtubule motor, dynein (14, 15). Recently,
wehaveshownthatactiveformsoftheproteintyrosinekinases
Src and Fyn are recruited to the chlamydial inclusion mem-
brane, where they colocalize in microdomains that are thought
to serve as a platform for interactions between dynein and the
chlamydial inclusion (16).
Src and Fyn belong to the Src family of nonreceptor
membrane-associatedtyrosinekinases.Src,Yes,andFynareubiq-
uitouslyexpressed,withsomefunctionalredundancy,whereasthe
otherfamilymembersareexpressedinsubsetsofspecializedcells.
Src and Fyn are involved in a variety of signaling pathways that
govern a broad range of cellular processes (17).
Here we show that Src-family kinases (SFKs) have multiple
functions in C. trachomatis development, including trafﬁcking of
nascentinclusionstothemicrotubuleorganizingcenter(MTOC)
and a necessary role in completion of the C. trachomatis intracel-
lular developmental cycle. The functional implications of these
phenotypesaresupportedbytheobservationthatchlamydialspe-
ciesthatdonotrecruitSrc-familykinasestotheirinclusionmem-
branes(16)donottrafﬁctotheMTOCandshowenhancedinclu-
sion development in cells deﬁcient in Src-family kinases.
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SFK activation is upregulated in C. trachomatis-infected cells.
Src-familykinaseactivityisregulatedbythephosphorylationstate
of tyrosine residues within the kinase. Enzymatic activity is up-
regulated in kinases that are phosphorylated at Tyr419 (human
Src numbering) and downregulated when phosphorylated at
Tyr530 (17). Active Src-family kinases are recruited to the C. tra-
chomatis inclusion membrane, where they are observed in mi-
crodomainsenrichedincholesterolandspeciﬁcchlamydialinclu-
sion membrane proteins (16). The intensity of the active Src
kinasesignalatthesemicrodomainsindicatesasigniﬁcantenrich-
mentattheinclusionmembrane(16).Src-familykinaseactivityis
upregulated in C. trachomatis-infected cells (Fig. 1A). This in-
creasedoesnotoccurinthepresenceofchloramphenicolandthus
is not simply a response by the host cell to the challenge of chla-
mydial infection. C. caviae, a species that does not recruit active
kinase to the inclusion membrane, does not induce activation of
Src-family kinases (Fig. 1B).
Src-family kinases are not required for C. trachomatis at-
tachmentorentry.TheroleofSrc-familykinasesatvariousstages
of the chlamydial development cycle was examined. SYF cells are
mouse embryonic ﬁbroblast cells that are null mutants for the
three ubiquitous Src-family kinases (Src, Yes, and Fyn). Src was
subsequently reintroduced to create the SYF  Src cell line (18).
Mouse L929 ﬁbroblasts were used as an additional control. Com-
parison of the numbers of attached and internalized C. trachoma-
tis L2 EBs indicates that the SYF cells showed no signiﬁcant defect
in bacterial attachment or invasion compared to L929 and SYF 
Srccells(seeFig.S1inthesupplementalmaterial).Thisisinagree-
ment with previous reports showing that inhibition of Src-family
kinases does not reduce C. trachomatis L2 invasion (19, 20).
Nascent C. trachomatis inclusions require SFKs for proper
trafﬁcking to the MTOC. Trafﬁcking of C. trachomatis L2 inclu-
sions to the MTOC was examined in L929, SYF, and SYF  Src
cells (Fig. 2). Nascent inclusions rapidly cluster at the MTOC in
L929 cells and SYF  Src cells. This is in contrast to the dispersed
inclusions observed in SYF cells or cultures in which bacterial
translation was blocked with chloramphenicol (Fig. S2). Approx-
imately the same percentages of cells with C. trachomatis EBs ag-
gregatedattheMTOCwereobservedinL929andSYFSrccells,
whereas in SYF cells this value was reduced to the minimal levels
seeninchloramphenicol-treatedcultures.Src-familykinaseactiv-
ity is thus required for the dynein-dependent trafﬁcking of the
nascent C. trachomatis inclusion to the MTOC.
C. trachomatis serovars L2 and D and C. pneumoniae recruit
FIG1 Src-family kinase activation in C. trachomatis-infected cells. Immuno-
blot analysis of cell lysate 24 h after infection with C. trachomatis L2 (A) or
C. caviae GPIC (B) in the absence or presence of chloramphenicol (CAM)
showsthatactiveSrc-familykinaseisupregulatedafterC.trachomatis,butnot
C.caviae,infection.Upregulationisdependentuponbacterialproteinsynthe-
sis, as it is inhibited by chloramphenicol. The concentrations of total kinase
(Fyn and Src) are unchanged. GAPDH is included as a loading control. MW,
molecular weight (in thousands).
FIG2 TrafﬁckingofnascentC.trachomatisinclusionstotheMTOCrequires
Src-family kinases. (A) L929, SYF, and SYF  Src cells were infected with
C. trachomatis L2 in the absence or presence of chloramphenicol. Five hours
postinfection, samples were ﬁxed and stained for EBs (green) and -tubulin
(red). Arrowheads indicate early inclusions converged at the MTOC. Bar,
10 m. (B) The percentage of cells with inclusions clustered at the MTOC is
signiﬁcantly decreased in SYF cells compared to that in L929 and SYF  Src
cells and approximates the percentage observed in chloramphenicol-treated
cells. One hundred infected cells were counted per sample (n  3); error bars
show standard deviations.
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C.caviaeandC.muridarumdonot(16).Weinvestigatedwhether
Src-family kinase recruitment might correlate with trafﬁcking to
the MTOC in a species-speciﬁc manner. Examination of infected
L929 cells conﬁrms that C. trachomatis and C. pneumoniae inclu-
sions consistently trafﬁc to the MTOC, whereas C. caviae and
C. muridarum inclusions do not (Fig. 3). These ﬁndings support
the conclusion that Src-family kinases play an essential role in the
trafﬁckingofchlamydialinclusionstotheMTOC.Examinationof
C. caviae and C. muridarum inclusions at later times conﬁrms a
lack of trafﬁcking to the MTOC (Fig. S3).
DifferentialeffectsofSFKdeﬁciencyonchlamydialdevelop-
ment. Although attachment and entry are unaffected, develop-
ment of C. trachomatis inclusions is signiﬁcantly reduced in SYF
cells compared to development in L929 or SYF  Src cells
(Fig. S4). Consistent with the observed inhibition of inclusion
development, the number of infectious progeny is decreased in
SYFcellstolessthan10%ofthatobtainedfromL929cells(Fig.4).
Reconstitution of Src largely restores infectious progeny produc-
tion, although a modest decrease is seen from the SYF  Src cells
relative to L929 cells, suggesting that Fyn or Yes may play speciﬁc
roles during chlamydial development for which Src does not pro-
vide functional redundancy.
Neither C. caviae nor C. muridarum displays a decrease in the
number of developed inclusions or in infectious progeny pro-
duced from SYF cells. Indeed, C. caviae and C. muridarum inclu-
sions in SYF cells appear signiﬁcantly larger than those in L929 or
SYFSrccells(Fig.5).Therewasacorrespondingincreaseinthe
numberofinfectiousprogenyproducedinSYFcells,withapprox-
imately an 800% and 20% increase over those produced in L929
cells for C. caviae and C. muridarum, respectively (Fig. 4).
BecausedepletionofSrc-familykinasesblocksbothtrafﬁcking
ofthenascentC.trachomatisinclusionstotheMTOCandnormal
inclusiondevelopment,weaskedwhetherinhibitionoftrafﬁcking
totheMTOCmightberesponsibleforthelackofinclusiondevel-
opment in SYF cells. As has been shown previously (14, 21), no-
codazole inhibits trafﬁcking of C. trachomatis inclusions to the
MTOCbutdoesnotimpairsubsequentinclusiondevelopmentor
production of infectious progeny (Fig. S5).
Src-familykinasesarenotrequiredforIncmicrodomainfor-
mation. Although few C. trachomatis inclusions develop in SYF
cells, those that do appear to develop normally (Fig. S6). In those
inclusions, Inc microdomains are observed on the inclusion
membrane. This is in agreement with previous observations that
Src-family kinases are not required for Inc microdomain forma-
tion (16). Active kinase colocalizes with Inc microdomains in
L929 cells, and the signal intensity is enhanced in cells overex-
pressing Src (SYF  Src), but the signal is not detected in cells
lacking Src-family kinases. However, tyrosine-phosphorylated
proteins are observed in microdomains at the inclusion mem-
brane in all three cell lines, although they appear more abundant
intheSYFSrccellsandlessabundantintheSYFcells.ActiveSrc
and Fyn are themselves tyrosine phosphorylated, which may ac-
countforthereducedphosphotyrosinesignalinSYFcellsandthe
increased signal observed in SYF  Src cells. However, it is likely
that there are tyrosine-phosphorylated proteins other than Src-
family kinases present in the microdomains.
Src-familykinaseinhibitorsmimictheinhibitoryeffectsob-
served in SYF cells. Given the phenotypes observed in SYF cells,
we investigated the ability of Src-family kinase inhibitors to reca-
FIG3 TrafﬁckingofnascentchlamydialinclusionstotheMTOCisspecies
speciﬁc. (A) L929 cells were infected with C. trachomatis L2, C. caviae
GPIC, C. muridarum MoPn, or C. pneumoniae AR39. Five hours postin-
fection, the cells were ﬁxed and labeled with anti-EB antisera (green) and
anti--tubulin antibodies (red) followed by DyLight 488 and 594 second-
ary antibodies as well as DRAQ5 DNA stain (blue). Arrowheads indicate
early inclusions converged at the MTOC. Bar, 10 m. (B) The percentage
of infected cells with EBs clustered at the MTOC was determined using
confocal ﬂuorescent microscopy. C. trachomatis L2 and C. pneumoniae
consistentlytrafﬁctothecentrosome,whereasC.caviaeandC.muridarum
do not. One hundred cells were counted per sample (n  3); error bars
show standard deviations. Cpn, C. pneumoniae.
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chomatis early inclusions to the MTOC was inhibited by the pro-
tein tyrosine kinase inhibitor SU6656 (Fig. S7). The effect of
SU6656 on C. trachomatis L2 and C. caviae progeny production
was also examined (Fig. 6A). Consistent with the effects observed
in SYF cells, the production of C. trachomatis progeny EBs was
reduced by over 95% by inhibition of Src-family kinases. Con-
versely, production of infectious progeny from C. caviae-infected
cells was unaffected by Src-family kinase inhibitors. The decreas-
ing viability of the host cells in the extended presence of inhibitor
preventedaccuratequantitationofinclusion-formingunits(IFU)
atlatertimepointswherethelargestincreaseinIFUfromSYFcells
was observed.
To further delineate the requirements for Src-family kinases
during C. trachomatis intracellular trafﬁcking and development,
we allowed nascent inclusions to trafﬁc to the MTOC before in-
hibiting Src-family kinase activity with SU6656. SU6656 reduced
progeny EB formation to 1.9%  0.6% and 3.1%  0.6% of un-
treated control values when added at 0 and 5 h postinfection,
respectively. Complementary to the results above demonstrating
that trafﬁcking to the MTOC is not necessary for C. trachomatis
development, these results indicate that trafﬁcking to the MTOC
isnotsufﬁcienttopromotenormaldevelopmentintheabsenceof
Src-familykinaseactivity.ThegrowthinhibitionofC.trachomatis
by Src-family kinase inhibition thus appears unrelated to effects
on microtubule trafﬁcking.
Because C. trachomatis and C. caviae have different natural
hosts,weexaminedthepossibilitythatthesespecies-speciﬁcchla-
mydial phenotypes might be related to the murine origin of the
Src-family kinase-knockout cells. Similar inhibition of C. tracho-
matis by SU6566 was observed in the human cells, while C. caviae
infectious progeny production was not disrupted (Fig. 6B). This
resultindicatesthatthedifferentialeffectsofSrc-familykinaseson
C. trachomatis and C. caviae replication are independent of the
host cell species.
DISCUSSION
Tyrosine phosphorylation of proteins is an important posttrans-
lationalregulatorofactivity.Src-familykinasescompriseaprom-
inent family of protein tyrosine kinases that play a central role in
multiplesignalingpathwaysthatregulateadiversearrayofcellular
activities,includingadhesion,migration,differentiation,cellcycle
progression,apoptosis,transcription,andintracellulartrafﬁcking
(17). The intimate relationship of intracellular pathogens with
eukaryotic host cells necessitates that they adapt to and manipu-
late host cellular processes. Accordingly, intracellular pathogens
subvertcellularsignalingpathwaysatseveralstagesofinfectionto
promote entry, replication, or release during their life cycles. Src-
family kinases have been shown to play important roles in the
pathogenesisofawiderangeofintracellularpathogens,including
viruses, parasites, and bacteria (22–31).
C. trachomatis interacts with Src-family kinases at multiple
stages during its intracellular development. The C. trachomatis
type III effector Tarp, which is secreted upon attachment and
implicatedintheentryprocessduetoitsactin-nucleatingactivity,
istyrosinephosphorylatedbySrc-familyorothertyrosinekinases
FIG4 ChlamydialdependencyonSrc-familykinasesforproductiveinfection
is species speciﬁc. Conﬂuent monolayers of L929, SYF, and SYF  Src cells
wereinfectedwithC.trachomatisL2,C.caviaeGPIC,orC.muridarumMoPn.
Cultures were lysed at 30 h postinfection, and the progeny EBs were replated
ontoconﬂuentmonolayersofHeLacells.At24hpostinfection,thenumberof
inclusions per ﬁeld was determined (10 ﬁelds per sample; n  3) using ﬂuo-
rescent microscopy. Values reported are relative to those obtained from L929
cells (L2, 4.7  107 IFU/ml; GPIC, 5.3  107 IFU/ml; MoPn, 7.4  107 IFU/
ml). Error bars show standard deviations.
FIG 5 Enhanced development of non-C. trachomatis inclusions in SYF cells.
L929, SYF, and SYF  Src cells were infected with C. caviae GPIC or C. muri-
darumMoPn.At24hpostinfection,sampleswerevisualizedusingﬂuorescent
confocal microscopy (bar, 10 m) (A) or transmission electron microscopy
(bar, 5 m) (B). Inclusions in SYF cells are much larger than corresponding
inclusions in L929 or SYF  Src cells.
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the role(s) of Tarp remains to be fully elucidated, the functions
associated with it are independent of chlamydial transcription or
translation(34)andthuscanbereadilydistinguishedfromevents
that are dependent upon chlamydial protein synthesis, such as
trafﬁcking to the MTOC (14), fusion with Golgi apparatus-
derivedvesicles(13),differentiationofchlamydialdevelopmental
forms (35), and activation of Src-family kinases.
C. trachomatis and C. pneumoniae also appear to have evolved
a dependency on Src-family kinases for intracellular trafﬁcking
and development. Recently, microdomains on the C. trachomatis
inclusion membrane were identiﬁed and shown to be comprised
of at least four inclusion membrane proteins as well as activated
Src-family kinases. These microdomains are thought to partici-
pate in the interactions of the chlamydial inclusion with the mi-
crotubule motor complex and function in the trafﬁcking of the
nascentinclusiontotheMTOC(16).InSYFcellsorcellsinwhich
Src-family kinases are inhibited, nascent C. trachomatis L2 inclu-
sions are not trafﬁcked to the MTOC and show a reduction in
inclusion development with a corresponding decrease in infec-
tious progeny. The two defects induced by a Src-family kinase
deﬁciencyappeartobeunrelated,sincethemicrotubuleinhibitor
nocodazoleeffectivelyblockstrafﬁckingofnascentC.trachomatis
inclusions to the MTOC without negatively affecting inclusion
developmentorproductionofinfectiousprogeny.Nascentinclu-
siontrafﬁckingisdependentuponmicrotubulesanddynein(14).
Src-familykinaseshavebeenshowntophosphorylatetubulinand
bind to dynein-associated proteins (36–38), suggesting that re-
cruitment of Src-family kinases by chlamydiae may directly or
indirectlymediatelinkageoftheinclusiontothemicrotubulenet-
work of the host cell. Those species examined that do not display
activeSrc-familykinase-enrichedmicrodomainsontheinclusion
membrane, C. muridarum and C. caviae, do not exhibit
microtubule-dependent trafﬁcking to or association with the
MTOC.WhetherSrc-familykinaseactivityisrequiredforproces-
sivityofthedyneinmotorcomplexorwhethertyrosinephosphor-
ylation contributes to the recruitment of necessary components
remains to be determined. An improved understanding of C. tra-
chomatis trafﬁcking may help to delineate the role of Src-family
kinases in dynein motor function and microtubule trafﬁcking.
Src-familykinasesalsoappeartoserveaseparatefunctionlater
in infection that is essential for normal C. trachomatis inclusion
development. The observation that those few EBs which differen-
tiateandcommittodevelopmentdosonormallysuggeststhatthis
critical initial step of differentiation may be a stochastic process
that does not favor C. trachomatis development in the absence of
Src-family kinases. This developmental defect is not observed in
SYF cells infected with C. caviae or C. muridarum. Indeed,
C.caviaeandC.muridarumreplicatemoreefﬁcientlyinSYFcells.
Although the mechanism of growth enhancement of C. caviae or
C. muridarum in cells deﬁcient in Src-family kinases is unknown,
one hypothesis might be that Src-family kinases play a role in a
pathway that restricts growth of these pathogens and that the ab-
sence of this pathway in SYF cells permits unregulated, enhanced
growth.
Chlamydialspeciesarewellknownfortheirdistincttissuetro-
pisms and species speciﬁcity, despite a high degree of synteny of
their genomes (39). Few loci have been associated with disease or
tissue tropism (40–44). Divergence occurs primarily within a hy-
pervariable replication termination region or plasticity zone (45).
A key distinction between human and murine chlamydial species
involves their adaptations to gamma interferon (IFN-) (46–49).
In murine cell lines and in vivo, C. muridarum is resistant to the
effects of IFN-, whereas C. trachomatis is inhibited. IFN--
mediated inhibition of C. trachomatis in murine cells has been
attributed to the presence of p47 or immunity-related GTPases
(IRGs), which are present in mice but largely absent from human
cells (47, 49). Resistance of C. muridarum to IFN- is thought to
berelatedtotheinactivationofspeciﬁcIRGsbythecytotoxinthat
is absent or truncated in C. trachomatis (47). However, treatment
of a human cell line with a Src-family kinase inhibitor led to a
decrease in C. trachomatis replication similar to that observed in
murine cells; thus, the mechanisms of the Src-family kinase ap-
pear to be acting though pathways other than mouse-speciﬁc
IRGs. IFN- treatment was not investigated here; however, the
plasticity zone remains a highly plausible locus for chlamydial
genes responsible for the divergent responses to Src-family kinase
depletion.
Early studies of tyrosine phosphorylation during chlamydial
infectiondescribedtwoormoreproteinsthatweretyrosinephos-
phorylated very early in infection and located in close apposition
FIG 6 Src-family kinase inhibitors inhibit production of C. trachomatis in-
fectious progeny. Conﬂuent monolayers of L929 (A) or HeLa (B) cells were
infected with C. trachomatis L2 or C. caviae GPIC. One hour postinfection,
cells were treated with DMSO (gray bars) or SU6656 (black bars). Cells were
lysed, and progeny was replated onto HeLa cell monolayers. Cells were ﬁxed
and ﬂuorescently labeled, and the number of inclusions per ﬁeld was counted
using ﬂuorescent microscopy. Values reported are relative to those obtained
frommock-treated(DMSO)controls(HeLacells:L2,1.1107IFU/ml;GPIC,
2.3  107 IFU/ml; L929 cells: L2, 1.0  108 IFU/ml; GPIC, 6.3  106 IFU/ml).
Ten ﬁelds per sample (n  3). Error bars show standard deviations.
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tiﬁed, they were presumed to be of host origin. To date, ezrin has
been the only host protein identiﬁed that is tyrosine phosphory-
latedduringchlamydialinvasion(52).Amorecompleteaccount-
ing of host and chlamydial proteins that are tyrosine phosphory-
latedthroughoutthedevelopmentalcyclewillundoubtedlyreﬁne
future studies designed to understand the mechanisms of growth
inhibitionofC.trachomatisandgrowthenhancementofC.caviae
and C. muridarum by depletion of Src-family kinases.
Protein tyrosine kinases are activated and functional at multi-
ple stages of C. trachomatis intracellular development. By all pa-
rametersanalyzed,C.caviaeandC.muridarumshowednoactiva-
tionof,recruitmentof,orrequirementforSrc-familykinasesand
thus have apparently evolved life-styles that circumvent the need
forSrc-familykinases.Src-familykinasesthereforeplayanimpor-
tant, but species-speciﬁc, role in the chlamydial developmental
cycle. It is apparent that different combinations of requirements
occur between species. For example, C. pneumoniae Tarp is not
phosphorylated (32), and yet its inclusions contain tyrosine-
phosphorylated microdomains (16) and are trafﬁcked to the
MTOC. It is likely that additional functions regulated by Src-
family kinases will be identiﬁed in chlamydia-infected cells. A
more complete understanding of host and chlamydial tyrosine-
phosphorylated proteins and the pathways associated with them
should help elucidate signiﬁcant questions in chlamydial biology
and pathogenesis.
MATERIALS AND METHODS
Organisms and cell culture. Chlamydia trachomatis serovar L2 (LGV
434)andserovarD(UW-3-Cx),ChlamydiamuridarumNigg,Chlamydo-
philacaviaeGPIC,andChlamydiapneumoniaeAR-39werepropagatedin
HeLa229cellsandpuriﬁedbyRenograﬁndensitygradientcentrifugation
as previously described (53). L929, SYF, and SYF  Src cells (American
Type Culture Collection [ATCC], Manassas, VA) were grown in Dulbec-
co’s modiﬁed Eagle’s medium (DMEM; ATCC) with 10% fetal bovine
serum(FBS;ATCC)andgentamicin(Gibco,Carlsbad,CA).TheSYFcells
used were between passage numbers 22 and 30.
Antibodies. The antichlamydia antibodies used were polyclonal rab-
bit anti-C. trachomatis L2 EB, anti-C. pneumoniae EB, and anti-C. caviae
EB. Monoclonal antibody L2-i-45 against C. trachomatis L2 major outer
membraneprotein(MOMP)waskindlyprovidedbyH.D.Caldwell.Rab-
bit anti-Inc101 was previously described (16). Anti-phospho-Src-family
Tyr416 clone 9A6 (Millipore, Billerica, MA) was used to detect active
Src-family kinases. Monoclonal antibody 4G10 (Millipore) was used to
detectphosphotyrosine.Centrosomesweredetectedusingmouseanti--
tubulin, clone GTU-88 (Sigma, St. Louis, MO). Anti-mouse or anti-goat
DyLight594andanti-rabbitDyLight488(JacksonImmunoResearchLab-
oratories,WestGrove,PA)wereusedassecondaryantibodiesforindirect
immunoﬂuorescence. Anti-Src (Cell Signaling, Danvers, MA), anti-Fyn
(BDBiosciences,SanDiego,CA),anti-glyceraldehyde-3-phosphatedehy-
drogenase (anti-GAPDH; Sigma), and horseradish peroxidase (HRP)-
conjugated donkey anti-rabbit IgG and HRP-conjugated donkey anti-
mouse IgG (Jackson ImmunoResearch Laboratories) were used for
immunoblotting.
Western blotting. HeLa cells were mock infected or infected with
C. trachomatis or C. caviae at a multiplicity of infection (MOI) of 1 or 20.
At 24 h postinfection, the cells were incubated with 1 mM sodium vana-
date for 30 minutes; rinsed with 50 mM NaPO4, 150 mM NaCl, pH 7.4
(phosphate-bufferedsaline[PBS]);andlysedinLaemmlibuffer(54)with
5% beta-mercaptoethanol and 1 mM sodium vanadate. The lysates were
separated by SDS-PAGE for immunoblotting as previously described
(16).
Attachment and invasion assays. Monolayers of L929, SYF, and SYF
 Src cells on glass coverslips in 24-well plates were chilled to 4°C on ice
for 30 minutes prior to addition of C. trachomatis L2 at an MOI of ~20
followed by a 30-minute incubation at 4°C. For attachment assays, cells
were rinsed once in cold Hanks’ balanced salt solution (HBSS) and ﬁxed
with methanol before immunostaining. Images of attached chlamydiae
wereobtainedusingaZeissLSM510Metalaserconfocalscanningmicro-
scope using a 20, 0.8-numerical-aperture (NA) objective (Carl Zeiss
MicroImaging, Inc., Maple Grove, MN), and the number of attached
bacteriawasdeterminedfor10ﬁeldspersample.Forinvasionassays,cells
were inoculated as described above, prewarmed medium was added, and
cultures were incubated at 37°C for 30 minutes prior to ﬁxation with 4%
paraformaldehyde (Electron Microscopy Sciences, Hatﬁeld, PA) in PBS.
Intracellular and extracellular bacteria were differentially stained by indi-
rectimmunoﬂuorescence,andthepercentageofinternalizedbacteriawas
calculated by subtracting the number of extracellular bacteria from the
total number of bacteria and dividing by the total number of bacteria as
previously described (55). A minimum of 10 cells and 100 bacteria were
counted for each sample.
Inclusion development and infectious progeny (IFU) assays. Con-
ﬂuentmonolayersofL929,SYF,andSYFSrccellsonglasscoverslipsor
Costar Cellbind (Corning, Lowell, MA) 24-well plates were infected with
C. trachomatis serovar L2 or D, C. muridarum,o rC. caviae as previously
described(16)atanMOIof~0.5.Attheindicatedtimespostinfection,the
cultures were ﬁxed in methanol or rinsed once and lysed in water and
disrupted by passage through a 26-gauge needle, before dilution in HBSS
and replating on HeLa cell monolayers for determination of inclusion-
forming units (IFU). Where indicated, nocodazole (Sigma) was added to
400 ng/ml at the time of infection. For Src inhibitor experiments, cells
were treated with dimethyl sulfoxide (DMSO; Sigma) or 10 M SU6656
(Sigma) 1 h after the initial infection and maintained in the continuous
presence of the drug.
Centrosomal clustering assays. Subconﬂuent monolayers of L929,
SYF,orSYFSrccellswereinfectedwithC.trachomatisserovarL2orD,
C. pneumoniae, C. muridarum,o rC. caviae at an MOI of ~20. At 5 h
postinfection, cells were rinsed and ﬁxed with methanol prior to labeling
with rabbit anti-EB and mouse anti--tubulin (Sigma). The specimens
werecounterstainedwithgoatanti-rabbitIgG-DyLight488andgoatanti-
mouse IgG-DyLight 594. The number of infected cells that had a mini-
mumoftwoEBsadjacenttoatleastonehostcentrosomewasdetermined
by ﬂuorescent microscopy using a Zeiss LSM 510 Meta laser confocal
scanningmicroscopewitha63,1.4-NAoilobjective.Aminimumof100
infected cells were counted for each sample, and experiments were per-
formedintriplicate.CellswereuntreatedortreatedwithDMSO,nocoda-
zole (400 ng/ml), or chloramphenicol (50 g/ml) concurrently with in-
fection.FortheSrcinhibitorexperiments,L929cellswerepretreatedwith
DMSOor10MSU6656for1hpriortoinfectionandmaintainedinthe
presence of inhibitor.
Electronmicroscopy.L929,SYF,andSYFSrcmonolayersonTher-
manoxcoverslipswereinfectedwithC.caviae.At24hpostinfection,cells
were ﬁxed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer
and processed for transmission electron microscopy as previously de-
scribed (16).
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